Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma

Pinczés, László ImreSzabó, RoxánaIllés, ÁrpádFöldeák, DóraPiukovics, KláraSzomor, ÁrpádGopcsa, LászlóMiltényi, Zsófia2020-08-242020-08-242020Annals of Hematology. -99 (2020), p. 2385-2392. -Ann. Hematol. - 0939-5555. - 1432-05840939-55551432-0584http://hdl.handle.net/2437/291704Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphomafolyóiratcikkopen access articlehttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM087490OrvostudományokKlinikai orvostudományokhttp://link.springer.com/10.1007/s00277-020-04204-1http://dx.doi.org/10.1007/s00277-020-04204-12021-03-18